Market Tracker

02/21 5:15pm ET

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

20.09
Delayed Data
As of Feb 21
 +0.11 / +0.55%
Today’s Change
10.85
Today|||52-Week Range
37.94
+6.02%
Year-to-Date
Einhorn Discusses Worst Ever Performance for Greenlight
Feb 21 / GuruFocus News - Paid Partner Content
Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles
Feb 16 / TheStreet.com - Paid Partner Content
Muhlenkamp & Co. 4th Quarter 2017 Shareholder Letter
Feb 21 / GuruFocus News - Paid Partner Content
Francis Chou Nearly Dumps Entire Stake in Valeant, Teva and Overstock in 4th Quarter
Feb 16 / GuruFocus News - Paid Partner Content
Teva's Problems Continue to Mount With No Relief in Sight
Feb 21 / Zacks.com - Paid Partner Content
Five-Day Winning Streak in Stocks Expected to Continue
Feb 16 / TheStreet.com - Paid Partner Content
Invest Like Warren Buffett With These ETFs
Feb 20 / Zacks.com - Paid Partner Content
Five Day Winning Streak Expected to Continue -- Market Recon
Feb 16 / TheStreet.com - Paid Partner Content
Should You Follow Buffett Into Teva Pharmaceutical?
Feb 20 / GuruFocus News - Paid Partner Content
J&J (JNJ) Gets FDA Nod for New Prostate Cancer Treatment (Revised)
Feb 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close19.98
Today’s open19.98
Day’s range19.70 - 20.61
Volume13,951,476
Average volume (3 months)24,301,293
Market cap$20.3B
Data as of 4:00pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)-23,426.50%
Earnings growth (this year)--
Earnings growth (next 5 years)-1.95%
Revenue growth (last year)+2.60%
P/E ratioNM
Price/Sales0.85
Price/Book1.48

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+14.26+10.51%
TYMETyme Technologies In...-0.06-1.75%
OASMOasmia Pharmaceutica...+0.02+1.12%
Data as of 4:00pm ET, 02/21/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)$0.71
Annual revenue (last year)$22.5B
Annual profit (last year)-$16.4B
Net profit margin-72.66%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Kåre Schultz
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts